Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(17)
•••
Comment by antisenseon Nov 06, 2019 10:51am
66 Views
Post# 30315575

RE:RE:RE:RE:Updated Results from Phase 2 SPiReL Study Evaluating IMV’s D

RE:RE:RE:RE:Updated Results from Phase 2 SPiReL Study Evaluating IMV’s DWhich results are we getting on Friday?

markthehare wrote: I wonder if the positive interest has anything to do witht the pending results on Friday

Hideaway wrote: The market seems to like the news. Up .22 cents at open,but we need more volume which I hope we will get soon. This should give WF an opportunity to start a more rigerous US promotion.
GLTA




Bullboard Posts
Dealroom for high-potential pre-IPO opportunities